Description
The growing interest in alternative routes of drug and vaccine administration has experts predicting that the market for microneedle drug/vaccine delivery systems could exceed $30 billion by 2030. The industry is on the threshold of bringing into commercial production a new generation of transformative skin-mediated delivery systems.
